CDC’s efforts with forecasting began in 2013 with the “Predict the Influenza Season Challenge”, a competition that encouraged outside academic and private industry researchers to forecast the timing, peak, and intensity of the flu season.
Changes were made in response to data becoming more difficult to interpret because of the ongoing COVID-19 pandemic.
Source: Centers for Disease Control and Prevention (CDC)
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more
